897732-75-1 Usage
General Description
3-PyridinaMine, 2-Methyl-6-(Methylsulfonyl)-, also known as Mefloquine, is a chemical compound used primarily as an antimalarial drug. It is a member of the quinoline class of antimalarial medications, and works by interfering with the growth of the malaria parasite in the red blood cells. Mefloquine is used both for the prevention and treatment of malaria, particularly in regions where the parasites have developed resistance to other antimalarial drugs. It is considered to be an effective and well-tolerated medication, but can have rare and serious side effects such as psychosis and seizures. Mefloquine is typically administered in tablet form, and is a valuable tool in the global effort to combat malaria.
Check Digit Verification of cas no
The CAS Registry Mumber 897732-75-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,7,7,3 and 2 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 897732-75:
(8*8)+(7*9)+(6*7)+(5*7)+(4*3)+(3*2)+(2*7)+(1*5)=241
241 % 10 = 1
So 897732-75-1 is a valid CAS Registry Number.
InChI:InChI=1S/C7H10N2O2S/c1-5-6(8)3-4-7(9-5)12(2,10)11/h3-4H,8H2,1-2H3
897732-75-1Relevant articles and documents
PROCESS FOR THE PREPARATION OF 4- [6-(6-METHANESULFONYL-2-METHYL-PYRIDIN-3-YLAMINO) -5-METHOXY-PYRIMIDIN-4-YLOXY]-PIPERIDINE-1-CARBOXYLIC ACID ISOPROPYL ESTER
-
Page/Page column 36, (2010/12/18)
The present invention is directed to a process for the preparation of 4-[6- (6-methanesulfonyl-2-methyl-pyhdin-3-ylamino)-5-methoxy-pyrimidin-4-yloxy]- piperidine-1 -carboxylic acid isopropyl ester, useful as glucose dependent insulinotropic receptor agonist, for the treatment of metabolic-related disorders and complications thereof, such as, diabetes and obesity.
HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE
-
Page/Page column 190-191, (2009/10/22)
The present invention relates to compounds and methods which may be useful as inhibitors of GPR119 for the treatment or prevention of metabolic, cardiovascular, and metabolic diseases.
